These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Hexa-CAF combination chemotherapy and other multiple-drug regimens in advanced ovarian carcinoma: present and future. Neijt JP; van Lindert AC; Vendrik CP; Roozendaal KJ; Struyvenberg A; Pinedo HM Neth J Med; 1979; 22(2):38-44. PubMed ID: 107464 [No Abstract] [Full Text] [Related]
24. Cisplatin, doxorubicin, and cyclophosphamide (PAC) in the treatment of mixed mesodermal tumor of the ovary. Wheelock J; Hancock K; Smith K Cancer Treat Rep; 1987 Dec; 71(12):1275-6. PubMed ID: 3690537 [No Abstract] [Full Text] [Related]
25. [Progress in the chemotherapy of ovarian cancer]. Honetz N Wien Med Wochenschr; 1982 Jul; 132(13-14):319-24. PubMed ID: 6291259 [No Abstract] [Full Text] [Related]
26. [Phase III study of cisplatin on gynecological malignancy]. Chen JT; Takizawa K; Kawana T; Kawagoe K; Yoshida R; Yoshikawa H; Mizuno M; Sakamoto S Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):710-9. PubMed ID: 6182259 [No Abstract] [Full Text] [Related]
27. Outcome of patients with recurrent adult-type granulosa cell tumors--a Taiwanese Gynecologic Oncology Group study. Wang PH; Sun HD; Lin H; Wang KL; Liou WS; Hung YC; Chiang YC; Lu CH; Lai HC; Chang TC; Taiwan J Obstet Gynecol; 2015 Jun; 54(3):253-9. PubMed ID: 26166336 [TBL] [Abstract][Full Text] [Related]
28. [A case of ovarian cancer with liver metastasis successfully treated by PAC therapy]. Yokoyama H; Murakami T; Akagi T; Sunahori K; Muta M Gan To Kagaku Ryoho; 1991 Jun; 18(7):1203-7. PubMed ID: 2053778 [TBL] [Abstract][Full Text] [Related]
29. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)--the mount sinai experience. Cohen CJ; Bruckner HW; Goldberg JD; Holland JF Clin Obstet Gynaecol; 1983 Aug; 10(2):307-24. PubMed ID: 6413114 [No Abstract] [Full Text] [Related]
31. [Effectiveness of 3-drug therapy in patients with advanced ovarian cancer]. Kwaśniewska-Rokicińska C; Kaleta B; Kumor-Głodny T Ginekol Pol; 1989 Feb; 60(2):86-9. PubMed ID: 2680790 [TBL] [Abstract][Full Text] [Related]
32. Continuous Intraoperative Intraperitoneal Hyperthermic Chemoperfusion (CIIPHCP) in the treatment of advanced stage and recurrent granulosa cell tumors. Report of two cases. Chatzigeorgiou K; Economou S; Zafiriou G; Minopoulos G; Manolas K; Chatzigeorgiou N Zentralbl Gynakol; 2002 Jul; 124(7):374-7. PubMed ID: 12439765 [TBL] [Abstract][Full Text] [Related]
33. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide. Gershenson DM; Copeland LJ; Kavanagh JJ; Stringer CA; Saul PB; Wharton JT Obstet Gynecol; 1987 Nov; 70(5):765-9. PubMed ID: 3658288 [TBL] [Abstract][Full Text] [Related]
34. [A case of granulosa cell tumor with unusual histologic features]. Nakayama T; Nakai Y; Tamura H; Nagano T; Shibamoto T; Ohara A; Ozawa M; Kurata A Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):367-70. PubMed ID: 1904472 [No Abstract] [Full Text] [Related]
35. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials. Thigpen T; Vance R; Puneky L; Khansur T Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816 [TBL] [Abstract][Full Text] [Related]
36. Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. The Ovarian Cancer Meta-Analysis Project. J Clin Oncol; 1991 Sep; 9(9):1668-74. PubMed ID: 1831495 [TBL] [Abstract][Full Text] [Related]
37. Importance of multiagent chemotherapy regimens in ovarian carcinoma: dose intensity analysis. Levin L; Simon R; Hryniuk W J Natl Cancer Inst; 1993 Nov; 85(21):1732-42. PubMed ID: 8411257 [TBL] [Abstract][Full Text] [Related]
38. Meta-analysis of cisplatin, doxorubicin, and cyclophosphamide versus cisplatin and cyclophosphamide chemotherapy of ovarian carcinoma. Fanning J; Bennett TZ; Hilgers RD Obstet Gynecol; 1992 Dec; 80(6):954-60. PubMed ID: 1333066 [TBL] [Abstract][Full Text] [Related]
39. Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I. Mäenpää J; Kangas L; Grönroos M Obstet Gynecol; 1985 Nov; 66(5):708-13. PubMed ID: 3932908 [TBL] [Abstract][Full Text] [Related]